deltatrials
Completed PHASE1/PHASE2 NCT00005615

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

The Florida Melanoma Trial: A Phase I/II Trial of Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa in the Treatment of Advanced Stage III Melanoma: Study Site & Coordinating Center

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Conditions Melanoma (Skin)
Interventions Interferon alfa Radiation therapy
Updated 6 times since 2017 Last updated: Sep 21, 2012 Started: Jul 31, 1997 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005

Listed as NCT00005615, this PHASE1/PHASE2 trial focuses on Melanoma (Skin) and remains completed. Sponsored by H. Lee Moffitt Cancer Center and Research Institute, it has been updated 6 times since 1997, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Jul 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lee Moffitt Cancer Center and Research Institute
  • National Cancer Institute (NCI)
Data source: H. Lee Moffitt Cancer Center and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Miami, United States
  • • Tampa, United States